In late June, the U.S. Supreme Court handed down a decision in Bilski v. Kappos, affirming a lower court’s ruling that business methods cannot be patented.
MassDevice asked Eric Raciti, a partner at international IP law firm Finnegan, to explain the ruling and its implications for the medical device industry. Raciti also discusses whether the industry’s reputation for litigiousness is deserved and how fledgling device makers should go about protecting their intellectual property:
